Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Gabapentin Enacarbil with/without Oxycodone
NCT06247488Phase 4Completed
- Start
- Jan 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin enacarbil in restless legs syndrome (RLS), postherpetic neuralgia (PHN). Started Jan 2022; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06247488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06247488.